Quantitative Assessment of Regional Pulmonary Transit Times in Pulmonary Hypertension. Issue 3 (9th July 2022)
- Record Type:
- Journal Article
- Title:
- Quantitative Assessment of Regional Pulmonary Transit Times in Pulmonary Hypertension. Issue 3 (9th July 2022)
- Main Title:
- Quantitative Assessment of Regional Pulmonary Transit Times in Pulmonary Hypertension
- Authors:
- Moore, Jackson E.
Cerne, John W.
Pathrose, Ashitha
Veer, Manik
Sarnari, Roberto
Ragin, Ann
Carr, James C.
Markl, Michael - Abstract:
- Abstract : Background: Pulmonary hypertension (PH) contributes to restricted flow through the pulmonary circulation characterized by elevated mean pulmonary artery pressure acquired from invasive right heart catheterization (RHC). MRI may provide a noninvasive alternative for diagnosis and characterization of PH. Purpose: To characterize PH via quantification of regional pulmonary transit times (rPTT). Study Type: Retrospective. Population: A total of 43 patients (58% female); 24 controls (33% female). RHC‐confirmed patients classified as World Health Organization (WHO) subgroups 1–4. Field Strength/Sequence: A 1.5 T/time‐resolved contrast‐enhanced MR Angiography (CE‐MRA). Assessment: CE‐MRA data volumes were combined into a 4D matrix (3D resolution + time). Contrast agent arrival time was defined as the peak in the signal‐intensity curve generated for each voxel. Average arrival times within a vessel region of interest (ROI) were normalized to the main pulmonary artery ROI (t0 ) for eight regions to define rPTT for all subjects. Subgroup analysis included grouping the four arterial and four venous regions. Intraclass correlation analysis completed for reproducibility. Statistical Tests: Analysis of covariance with age as covariate. A priori Student's t ‐tests or Wilcoxon rank‐sum test; α = 0.05. Results compared to controls unless noted. Significant without listing P value. ICC ran as two‐way absolute agreement model with two observers. Results: PH patients demonstratedAbstract : Background: Pulmonary hypertension (PH) contributes to restricted flow through the pulmonary circulation characterized by elevated mean pulmonary artery pressure acquired from invasive right heart catheterization (RHC). MRI may provide a noninvasive alternative for diagnosis and characterization of PH. Purpose: To characterize PH via quantification of regional pulmonary transit times (rPTT). Study Type: Retrospective. Population: A total of 43 patients (58% female); 24 controls (33% female). RHC‐confirmed patients classified as World Health Organization (WHO) subgroups 1–4. Field Strength/Sequence: A 1.5 T/time‐resolved contrast‐enhanced MR Angiography (CE‐MRA). Assessment: CE‐MRA data volumes were combined into a 4D matrix (3D resolution + time). Contrast agent arrival time was defined as the peak in the signal‐intensity curve generated for each voxel. Average arrival times within a vessel region of interest (ROI) were normalized to the main pulmonary artery ROI (t0 ) for eight regions to define rPTT for all subjects. Subgroup analysis included grouping the four arterial and four venous regions. Intraclass correlation analysis completed for reproducibility. Statistical Tests: Analysis of covariance with age as covariate. A priori Student's t ‐tests or Wilcoxon rank‐sum test; α = 0.05. Results compared to controls unless noted. Significant without listing P value. ICC ran as two‐way absolute agreement model with two observers. Results: PH patients demonstrated elevated rPTT in all vascular regions; average rPTT increase in arterial and venous branches was 0.85 ± 0.15 seconds (47.7%) and 1.0 ± 0.18 seconds (16.9%), respectively. Arterial rPTT was increased for all WHO subgroups; venous regions were elevated for subgroups 2 and 4 (group 1, P = 0.86; group 3, P = 0.32). No significant rPTT differences were found between subgroups ( P = 0.094–0.94). Individual vessel ICC values ranged from 0.58 to 0.97. Data Conclusion: Noninvasive assessment of PH using standard‐of‐care time‐resolved CE‐MRA can detect increased rPTT in PH patients of varying phenotypes compared to controls. Level of Evidence: 1 Technical Efficacy: Stage 3. … (more)
- Is Part Of:
- Journal of magnetic resonance imaging. Volume 57:Issue 3(2023)
- Journal:
- Journal of magnetic resonance imaging
- Issue:
- Volume 57:Issue 3(2023)
- Issue Display:
- Volume 57, Issue 3 (2023)
- Year:
- 2023
- Volume:
- 57
- Issue:
- 3
- Issue Sort Value:
- 2023-0057-0003-0000
- Page Start:
- 727
- Page End:
- 737
- Publication Date:
- 2022-07-09
- Subjects:
- pulmonary hypertension -- MR angiography -- pulmonary transit time -- time‐resolved contrast‐enhanced MRA -- thoracic
Magnetic resonance imaging -- Periodicals
616 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1522-2586 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/jmri.28343 ↗
- Languages:
- English
- ISSNs:
- 1053-1807
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5010.791000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25969.xml